Evidence map›Paper›PMID 37173725›Full record

ArticleJournal of cheminformatics2023

UmetaFlow: an untargeted metabolomics workflow for high-throughput data processing and analysis.

Eftychia E Kontou, Axel Walter, Oliver Alka, Julianus Pfeuffer, Timo Sachsenberg, Omkar S Mohite, Matin Nuhamunada, Oliver Kohlbacher, Tilmann Weber

Open access · goldAbstract read
In one paragraph

Article in Journal of cheminformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. LC-MS Data Processing Using OpenMS.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Advancing the Chemical Characterization ofPlants (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Fosfomycin Uptake inACS infectious diseases · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Eftychia E KontouThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet Building 220, 2800, Kgs. Lyngby, Denmark.
Axel WalterApplied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, Sand 14, 72076, Tübingen, Germany.
Oliver AlkaApplied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, Sand 14, 72076, Tübingen, Germany.
Julianus PfeufferVisual and Data-Centric Computing, Zuse Institute Berlin, Takustr. 7, 14195, Berlin, Germany.
Timo SachsenbergApplied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, Sand 14, 72076, Tübingen, Germany.
Omkar S MohiteThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet Building 220, 2800, Kgs. Lyngby, Denmark.
Matin NuhamunadaThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet Building 220, 2800, Kgs. Lyngby, Denmark.
Oliver KohlbacherApplied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, Sand 14, 72076, Tübingen, Germany.
Tilmann WeberThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet Building 220, 2800, Kgs. Lyngby, Denmark. tiwe@biosustain.dtu.dk.
Novo Nordisk Foundation · DKUniversity of Tübingen · DEUniversity Children's Hospital Tübingen · DEZuse Institute Berlin · DE

Funding

Bundesministerium für Bildung und Forschung FKZ: 31A535ADeutsche Forschungsgemeinschaft TRR 261/1, Z03Forschungscampus MODAL 3FO18501Novo Nordisk Fonden NNF20CC0035580
6 · The paper itself

Abstract

Metabolomics experiments generate highly complex datasets, which are time and work-intensive, sometimes even error-prone if inspected manually. Therefore, new methods for automated, fast, reproducible, and accurate data processing and dereplication are required. Here, we present UmetaFlow, a computational workflow for untargeted metabolomics that combines algorithms for data pre-processing, spectral matching, molecular formula and structural predictions, and an integration to the GNPS workflows Feature-Based Molecular Networking and Ion Identity Molecular Networking for downstream analysis. UmetaFlow is implemented as a Snakemake workflow, making it easy to use, scalable, and reproducible. For more interactive computing, visualization, as well as development, the workflow is also implemented in Jupyter notebooks using the Python programming language and a set of Python bindings to the OpenMS algorithms (pyOpenMS). Finally, UmetaFlow is also offered as a web-based Graphical User Interface for parameter optimization and processing of smaller-sized datasets. UmetaFlow was validated with in-house LC-MS/MS datasets of actinomycetes producing known secondary metabolites, as well as commercial standards, and it detected all expected features and accurately annotated 76% of the molecular formulas and 65% of the structures. As a more generic validation, the publicly available MTBLS733 and MTBLS736 datasets were used for benchmarking, and UmetaFlow detected more than 90% of all ground truth features and performed exceptionally well in quantification and discriminating marker selection. We anticipate that UmetaFlow will provide a useful platform for the interpretation of large metabolomics datasets.

Indexed as

AnalysisHigh-throughput workflowProcessingSoftwareUntargeted metabolomics

Identifiers

PMID37173725
PMCPMC10176759
OpenAlexW4376630013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.